Abdelaziz Toumi, PhD; Senior Director, Head of Commercial Solutions Ibex™ Design & Develop
Noel Smith, PhD; Head of Immunology, Applied Protein Services
Advancing an innovative drug from late stage discovery into the clinic is the most-critical step in drug product development. While drug developers would like to gain as much information on the product as possible, the scientific focus must be on the drug design for optimal efficacy and safety at this stage.
This is when key decisions are made that have a long-term impact and pave the way for clinical and commercial manufacturing as well as the future supply chain. In this early phase, it is less about speed, and more important to focus on quality from the start. During this webinar, we will discuss and discover: